Log In
Print this Print this

Edurant, rilpivirine (TMC278)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionDiarylpyrimidine non-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target DNA polymerase
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in treatment-naïve patients; Treat HIV-1 infection
Regulatory Designation Japan - Orphan Drug (Treat HIV-1 infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today